Brock Lesnar is scheduled to meet the Nevada State Athletic Commission on August 23, but Jon Jones’ hearing has yet to be announced.
Both men failed random, out-of-competition drug tests conducted by the United States Anti-Doping Agency (USADA), testing positive for the same estrogen blocker: clomiphene. ‘Bones’ also flagged for letrozole, another anti-estrogen agent.
Jones, who captured the interim light heavyweight title after beating Ovince Saint Preux at UFC 197, was pulled from his title unification bout with Daniel Cormier after the results of his June 16 test came back just days before UFC 200. Lesnar, on the other hand, went on to beat Mark Hunt in the co-main event because the results of his test didn’t come back until July 15, one week after UFC 200.
Jones, who has been involved in a series of controversial incidents over the last two years, released an emotional statement during a pre-UFC 200 press conference. The troubled light heavyweight claimed to have not knowingly taken any performance-enhancing drugs, while Lesnar assured fans that he will ‘get to the bottom’ of the issue.
As reported by Steven Marrocco of MMA Junkie, Lesnar’s hearing will be conducted on Aug. 23, where it’s expected that the former UFC heavyweight champion will receive a temporary suspension by the NSAC. Both Lesnar and Jones are also eligible to receive suspensions from the USADA.
About the author
